Mar 24, 2026 4:01 pm EDT CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
Mar 11, 2026 8:00 am EDT COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
Feb 26, 2026 8:00 am EST CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
Feb 23, 2026 7:00 am EST CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
Feb 17, 2026 7:00 am EST CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
Nov 26, 2025 7:30 am EST Collplant Biotechnologies Reports 2025 Third Quarter Financial Results And Provides Corporate Update
Nov 18, 2025 7:00 am EST Collplant Biotechnologies Announces Date For 2025 Third Quarter Financial Results
Oct 27, 2025 7:01 am EDT CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
